ストックスクリーナーアプリを入手
17.63
1.34%
-0.26
Novocure Ltd (NVCR) 最新ニュース
Dimensional Fund Advisors LP Sells 3,016 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect? - Yahoo Finance
Tower Research Capital LLC TRC Sells 6,669 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
Raymond James Financial Inc. Purchases Shares of 11,672 NovoCure Limited (NASDAQ:NVCR) - Defense World
Investor Network: Novocure Ltd. to Host Earnings Call - ACCESS Newswire
NovoCure Limited (NASDAQ:NVCR) Given Average Rating of “Moderate Buy” by Analysts - Defense World
NovoCure Ltd (NVCR)’s Market Momentum: Closing Strong at 20.62, Down -3.28 - DWinneX
Envestnet Asset Management Inc. Buys New Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World
Mariner LLC Acquires Shares of 8,631 NovoCure Limited (NASDAQ:NVCR) - Defense World
Comparing Meihua International Medical Technologies (NASDAQ:MHUA) & NovoCure (NASDAQ:NVCR) - Defense World
Ratio Analysis: Unpacking NovoCure Ltd (NVCR)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
A year in review: NovoCure Ltd (NVCR)’s performance in the last year - uspostnews.com
Wall Street Analysts See a 91.92% Upside in NovoCure (NVCR): Can the Stock Really Move This High? - Yahoo Finance
NovoCure Ltd’s latest rating changes from various analysts - knoxdaily.com
What is NovoCure Ltd (NVCR) Stock Return on Shareholders’ Capital? - Sete News
Russell Investments Group Ltd. Sells 2,135 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure First Quarter 2025 Earnings: Beats Expectations - simplywall.st
H.C. Wainwright maintains Buy on NovoCure, $38 price target By Investing.com - Investing.com Canada
NovoCure Ltd [NVCR] Shares Jump Approximately 56.80% Over the Year - knoxdaily.com
Why NovoCure Stock Skyrocketed This Week - Yahoo Finance
H.C. Wainwright maintains Buy on NovoCure, $38 price target - Investing.com
NovoCure Limited (NASDAQ:NVCR) Q1 2025 Earnings Call Transcript - Insider Monkey
NovoCure (NASDAQ:NVCR) Cut to “Sell” at StockNews.com - Defense World
NovoCure (NASDAQ:NVCR) Shares Gap Up After Earnings Beat - Defense World
NovoCure: Q1 Earnings Snapshot - Huron Daily Tribune
Bank of Montreal Can Buys New Position in NovoCure Limited (NASDAQ:NVCR) - Defense World
Decoding NovoCure Ltd (NVCR): A Strategic SWOT Insight - GuruFocus
Novocure’s Q1 2025: Revenue Growth and Strategic Advances - TipRanks
NovoCure (NVCR) Stock Rises on Strong Quarterly Earnings - GuruFocus
NovoCure Ltd. Earnings Call: Growth Amid Financial Challenges - TipRanks
Novocure (NVCR) Sees Early Revenue from Lung Cancer Treatments | NVCR Stock News - GuruFocus
NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025 - Benzinga
Novocure’s device for metastatic NSCLC treatment gains CE Mark - MSN
NovoCure (NVCR) Reports Strong Q1 Revenue Growth Amid Optune Lua Expansion - GuruFocus
Stocks of NovoCure Ltd (NVCR) are poised to climb above their peers - Sete News
NovoCure Surpasses Q1 Expectations - Mitrade
NovoCure (NVCR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
NovoCure Surpasses Q1 Expectations - The Motley Fool
NovoCure Ltd Reports Q1 2025 Earnings: EPS Loss of $0.31 Beats E - GuruFocus
Novocure Ltd earnings beat by $0.18, revenue topped estimates - Investing.com India
Novocure Reports First Quarter 2025 Financial Results | NVCR Sto - GuruFocus
Novocure (NVCR) Surpasses Q1 Revenue Projections, Reports $154.9 - GuruFocus
NovoCure Ltd Reports Q1 2025 Earnings: EPS Loss of $0.31 Beats Estimate, Revenue of $155 Million Exceeds Expectations - GuruFocus
Novocure Reports First Quarter 2025 Financial Results - TradingView
NovoCure Ltd SEC 10-Q Report - TradingView
Novocure to present Phase 3 PANOVA-3 trial results at ASCO 2025 - TipRanks
0.73%
0.15%
大文字化:
|
ボリューム (24 時間):